Design, synthesis and evaluation of novel N -hydroxybenzamides/ N -hydroxypropenamides incorporating quinazolin-4(3 H )-ones as histone deacetylase inhibitors and antitumor agents
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 76, 258-267
Abstract
No abstract availableKeywords
Funding Information
- National Foundation for Science and Technology of Vietnam (104.01-2016.12)
- Korean government (2017R1A5A2015541)
This publication has 30 references indexed in Scilit:
- Synthesis, bioevaluation and docking study of 5-substitutedphenyl-1,3,4-thiadiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agentsJournal of Enzyme Inhibition and Medicinal Chemistry, 2013
- Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell ViabilityJournal of Biological Chemistry, 2013
- Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agentsBioorganic & Medicinal Chemistry Letters, 2011
- Zinc Chelation with Hydroxamate in Histone Deacetylases Modulated by Water Access to the Linker Binding ChannelJournal of the American Chemical Society, 2011
- Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitorsEuropean Journal of Medicinal Chemistry, 2009
- Synthesis and Evaluation of Tripodal Peptide Analogues for Cellular Delivery of PhosphopeptidesJournal of Medicinal Chemistry, 2007
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Antitumor activity of unsaturated fatty acid esters of 4′-demethyldeoxypodophyllotoxinBioorganic & Medicinal Chemistry Letters, 2003
- Antiinvasive, antiangiogenic and antitumour activity of Ephedra sinica extractPhytotherapy Research, 2003
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990